# Omada Health Inc. (OMDA) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Medical Devices & Supplies. Price $18.58, market value $1.1 billion.

## Valuation
- **P/E (trailing): 77.4×**. Omada Health Inc. trades at 77.4× trailing earnings. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 33.4×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.35**. A PEG of 0.35 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 3.7×**. Each dollar of revenue is priced at 3.7×.
- **Price / book: 4.5×**. The shares trade at 4.5× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 168.5×**. Enterprise value is 168.5× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 2.0%** (5-yr avg 2.9%). Free cash flow equals 2.0% of the market value, below its five-year average of 2.9%, so the shares are pricier on cash than usual.
- **Earnings yield: 1.3%**. The inverse of the P/E: 1.3% of the price is earned each year.

## Profitability
- **Gross margin: 68.2%**. Omada Health Inc. keeps 68.2% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -0.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -4.9%**. The company reported a net loss over the last twelve months.
- **Return on equity: -5.6%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -4.8%**. Return on all capital, debt included, is -4.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 1.4%**. Each dollar of assets produces 1.4% of profit.

## Growth
- **Revenue growth (1 yr): 53.2%**. Revenue grew 53.2% over the last year.
- **EPS growth (1 yr): 94.3%**. Earnings per share rose 94.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Omada Health Inc. holds more cash than debt.
- **Current ratio: 3.60** (quick 3.60). Current assets cover the next year's liabilities 3.60 times.
- **Altman Z-score: 11.56**. A Z-score of 11.56 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Omada Health Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (12 analysts). 12 analysts cover Omada Health Inc.; the consensus is buy, with an average price target of $28.17 (+52% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -27.4%** (YTD 13.1%, 3-mo -13.0%). The shares are down 27.4% over twelve months including dividends.
- **From 52-week high: -27.4%** (80.7% above the low). Trading 27% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 39**. An RSI of 39 is neutral.
- **Beta (1 yr): 1.27** (volatility 63%). Beta of 1.27 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OMDA · Page: https://foliofundamentals.com/stocks/omda

Not investment advice.